Order Article Reprints

Rafeeq M, Al-Abbasi FA, Afzal M, Moglad E, Al-Qahtani SD, Alzrea SI, Almalki NAR, Imam F, Sayyed N, Kazmi I. 6-Shogaol Abrogates Parkinson’s Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B. Pharmaceuticals. 2024; 17(10):1348. https://doi.org/10.3390/ph17101348

Rafeeq, Misbahuddin, Fahad A. Al-Abbasi, Muhammad Afzal, Ehssan Moglad, Salwa D. Al-Qahtani, Sami I. Alzrea, Naif A. R. Almalki, Faisal Imam, Nadeem Sayyed, and Imran Kazmi. 2024. "6-Shogaol Abrogates Parkinson’s Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B" Pharmaceuticals 17, no. 10: 1348. https://doi.org/10.3390/ph17101348

Rafeeq, M., Al-Abbasi, F. A., Afzal, M., Moglad, E., Al-Qahtani, S. D., Alzrea, S. I., Almalki, N. A. R., Imam, F., Sayyed, N., & Kazmi, I. (2024). 6-Shogaol Abrogates Parkinson’s Disease in Rotenone-Induced Rodents: Based on In Silico Study and Inhibiting TNF-α/NF-κB/IL-1β/MAO-B. Pharmaceuticals, 17(10), 1348. https://doi.org/10.3390/ph17101348